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SUMMARY 
Neural circuits in the cerebral cortex consist of excitatory pyramidal cells and inhibitory 
interneurons. These two main classes of cortical neurons follow largely different genetic 
programs, yet they assemble into highly specialized circuits during development following 
a very precise choreography. Previous studies have shown that signals produced by 
pyramidal cells influence the migration of cortical interneurons, but the molecular nature of 
these factors have remained elusive. Here we identified Neuregulin 3 (Nrg3) as a 
chemoattractive factor expressed by developing pyramidal cells that guides the allocation 
of cortical interneurons in the developing cortical plate. Gain- and loss-of-function 
approaches reveal that Nrg3 modulates the migration of interneurons into the cortical 
plate in a process that is dependent on the tyrosine kinase receptor ErbB4. Perturbation of 
Nrg3 signaling in conditional mutants leads to abnormal lamination of cortical 
interneurons. Nrg3 is therefore a critical mediator in the assembly of cortical inhibitory 
circuits. 
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INTRODUCTION 
The balance of excitation and inhibition is crucial for the normal functioning of the 
cerebral cortex (Vogels and Abbott, 2009; Xue et al., 2014; Yizhar et al., 2011), yet the 
mechanisms controlling the assembly of excitatory pyramidal cells and inhibitory gamma-
aminobutyric acid-containing (GABAergic) interneurons into common circuits are poorly 
understood. Although most neural circuits consist of different classes of neurons, the 
cerebral cortex is relatively unique in that excitatory and inhibitory neurons are born in 
distinct progenitor regions of the embryonic telencephalon (Marín and Rubenstein, 2001; 
Wonders and Anderson, 2006), and therefore their assembly requires the precise 
coordination of two largely different migration programs (Marín and Rubenstein, 2003).  
Cortical GABAergic interneurons are highly heterogeneous and comprise distinct 
functional classes with unique morphological, electrophysiological and molecular features 
(Tremblay et al., 2016). Recent transcriptomic analyses in the mouse suggest that the 
neocortex contains over 20 molecularly distinct classes of interneurons (Tasic et al., 2016; 
Zeisel et al., 2015), a number comparable to those identified in the hippocampus through 
morphological and electrophysiological studies (Klausberger and Somogyi, 2008). 
Nevertheless, neocortical interneurons can be classified into several cardinal groups based 
on their developmental origin and the expression of key molecular markers (Tremblay et 
al., 2016). The large majority of cortical interneurons derives from the embryonic medial 
ganglionic eminence (MGE) and comprises two major classes: Parvalbumin-expressing 
(PV+) fast spiking interneurons such as chandelier cells and basket cells, and 
Somatostatin-expressing (SST+) interneurons comprising mostly Martinotti cells. 
Our understanding of the mechanisms controlling the development of cortical 
interneurons has increased exponentially since Anderson and colleagues discovered the 
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origin of cortical interneurons in the embryonic subpallium (Anderson et al., 1997). 
However, while the mechanisms controlling the tangential migration of interneurons from 
the ganglionic eminences towards the cortex have been widely explored (Baudoin et al., 
2012; Flames et al., 2004; Hernández-Miranda et al., 2011; Marín, 2013; Marín et al., 
2001; Nóbrega-Pereira et al., 2008; Polleux et al., 2002; Pozas and Ibañez, 2005; Rakic et 
al., 2015; van den Berghe et al., 2013), the cellular and molecular events governing the 
final allocation of interneurons in their corresponding cortical layers remain largely 
unknown. Interneurons follow two main routes of migration as they disperse tangentially 
throughout the cortex, the marginal zone (MZ) and the subventricular zone (SVZ) (Lavdas 
et al., 1999; Marín and Rubenstein, 2001; Miyoshi and Fishell, 2011; Tanaka et al., 2009). 
Interneurons initially avoid migrating into the cortical plate (CP), where pyramidal cells 
differentiate and form the different cortical layers (López-Bendito et al., 2008). 
Chemokines are responsible for maintaining migrating interneurons in their migratory 
streams (Tiveron et al., 2006), and deficits in this signaling system lead to laminar and 
regional defects in the distribution of cortical interneurons (Li et al., 2008; López-Bendito 
et al., 2008; Sánchez-Alcaniz et al., 2011; Wang et al., 2011). These results revealed that 
the timing of CP invasion is crucial for the final allocation of interneurons in cortical 
layers, but the molecular factors controlling this process have not yet been identified.  
Neuregulins comprise a large family of widely expressed epidermal growth factor 
(EGF)-like proteins that regulates multiple aspects of neurodevelopment, including 
neuronal migration, axon guidance, myelination, and synapse formation (Mei and Nave, 
2014; Mei and Xiong, 2008). Neuregulins are EGF domain-containing proteins encoded by 
six individual genes that activate receptor tyrosine kinases of the ERBB family, and some 
of the members of this signaling network have been shown to play crucial roles in the 
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assembly of GABAergic circuits (Rico and Marín, 2011). In particular, ErbB4 is highly 
expressed by interneurons migrating from the MGE (Rakic et al., 2015; Villar-Cervino et 
al., 2015; Yau et al., 2003), most notably among PV+ interneurons (Fazzari et al., 2010; 
Vullhorst et al., 2009). ErbB4 is required for the tangential migration of GABAergic 
interneurons from the subpallium to the developing cortex, and this effect is mediated by 
different isoforms of Nrg1 (Flames et al., 2004; Rakic et al., 2015). Here, we have 
identified Nrg3 as a chemoattractive factor regulating the final allocation of GABAergic 
interneurons in the cortex. Our results demonstrate that ErbB4-mediated Nrg3 signaling 
controls CP entry by GABAergic interneurons and influences their final laminar allocation. 
Together with previous results, our observations unravel a hierarchical system of 
chemoattractive signals that regulate the distribution of interneurons in the cerebral cortex. 
 6 
RESULTS 
A candidate gene approach to identify factors regulating cortical plate 
invasion by interneurons 
Different studies have shown that the chemokine Cxcl12 is responsible for maintaining the 
migration of interneurons within the MZ and the SVZ as they disperse tangentially 
throughout the cortex (Li et al., 2008; López-Bendito et al., 2008; Sánchez-Alcaniz et al., 
2011; Stumm et al., 2007; Tiveron et al., 2006; Wang et al., 2011). Genetic deletion of 
chemokine receptors (Abe et al., 2014; Sánchez-Alcaniz et al., 2011; Tiveron et al., 2006; 
Vogt et al., 2014; Wang et al., 2011) or acute inhibition of chemokine signaling (Lysko et 
al., 2014) (Figure S1, Movie S1 and S2) lead to the rapid accumulation of interneurons in 
the CP, which suggests the existence of chemoattractive signals in this region regulating 
the final allocation of interneurons. 
We took a candidate gene approach to identify molecules regulating the migration of 
interneurons into the CP. We hypothesized that factors relevant for this process might be 
upregulated in pyramidal cells at the time interneurons invade the CP. To analyze gene 
expression in equivalent cohorts of pyramidal cells, we performed in utero electroporation 
experiments with a plasmid encoding GFP targeting the dorsal pallium of E14.5 mice 
(Figure 1A). We then used fluorescence activated cell sorting (FACS) to isolate GFP+ 
pyramidal cells from these experiments at two different stages: E17.5, when pyramidal 
cells are still migrating towards the CP, and postnatal day (P) 4, when pyramidal cells have 
already reached their final position (Figure 1B–D). To examine the differential gene 
expression at these two stages in the development of pyramidal cells, we customized a 
TaqMan array with ∼100 genes known to be involved in neuronal migration, adhesion and 
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axon guidance during corticogenesis (Table S1), including members of the eph, ephrin, 
semaphorin, plexin, cadherin, protocadherin and neuregulin families. We also included 
several genes known to encode proteins expressed in pyramidal cells, such as Cux1 and 
Tbr1, as positive controls, and genes that encode proteins exclusively expressed in 
interneurons, such as Cxcr7, Cxcr4, Sst, Lhx6 and Htr3a, as negative controls. 
We identified 44 genes that are differentially expressed between the two stages 
(Figure 1E and Table S2). We focused our attention on 18 genes that are significantly more 
expressed by pyramidal cells at P4 compared to E17.5, because these are more likely to be 
involved in the chemoattraction of interneurons into the CP. To examine the pattern of 
expression of these genes, we performed in situ hybridization at E17.5 and P4 for this later 
list of candidate genes (Cdh6, Cdh20, Epha6, Epha10, Ephb2, Ephb3, Ephb6, Efna3, 
Efna5, Efnb3, Plxndc2, Plxna1, Plxnd1, Pcdh9, Pcdh15, Pcdh20, Nrg3, and Sema7a). 
Analysis of the expression of candidate genes revealed different patterns. For example, 
some genes were preferentially expressed in superficial layers of the cortex, and their 
expression increased during early postnatal stages (Figure S2A–F). In other cases, 
candidate genes were expressed throughout all layers of the neocortex (Figure S2G–H).  
Nrg3 is expressed in the developing cortical plate 
We noticed that one of the genes that is expressed throughout the CP and that is 
significantly more expressed by pyramidal cells at later stages is Neuregulin 3 (Nrg3), a 
member of the neuregulin family. In vitro experiments have shown that Nrg3 binds 
preferentially to ErbB4 receptors (Zhang et al., 1997), which are highly enriched in 
migrating cortical interneurons and excluded from pyramidal cells (Fazzari et al., 2010; 
Flames et al., 2004; Vullhorst et al., 2009; Yau et al., 2003). Based on this evidence, we 
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hypothesized that Nrg3 might regulate the intracortical migration of GABAergic 
interneurons, and focused our subsequent work on this molecule. 
We investigated the pattern of expression of Nrg3 in the developing cortex from mid-
embryonic until early postnatal stages using in situ hybridization (Figure 2). We observed 
that Nrg3 is highly expressed in the developing CP since its inception, and that Nrg3 
expression is maintained in pyramidal cells as they mature and start forming differentiated 
layers. Pyramidal cells therefore express Nrg3 as soon as they reach the CP, and its 
expression is subsequently maintained throughout all layers of the neocortex, including the 
subplate. Nrg3 is however largely absent from the MZ and the SVZ at all stages examined 
(Figure 2). These results support the hypothesis that Nrg3 might be involved in the 
regulation of interneuron migration into the CP.  
Nrg3 is a short-range chemoattractant for MGE-derived interneurons 
We have previously shown that different isoforms of Nrg1 act both as short- and long-
range chemoattractive molecules for tangentially migrating interneurons (Flames et al., 
2004). To examine whether Nrg3 may exert a similar effect on cortical interneurons, we 
performed confrontation assays in three-dimensional matrices in which we cultured MGE 
explants obtained from E13.5 GFP-expressing embryos together with aggregates of COS 
cells transfected with control or Nrg3 encoding plasmids (Figure 3A1). In parallel 
experiments, we carried out co-cultures in which COS cells were transfected with Ig-Nrg1, 
which encodes for a diffusible form of Nrg1. As described before (Flames et al., 2004), we 
observed that Ig-Nrg1 exerts a prominent chemoattractive response in MGE-derived cells 
(Figure 3B, 3C, and 3H). In contrast, we found no significant differences in the response of 
MGE-derived cells to Nrg3 compared to controls (Figure 3B, 3D, and 3H). Thus, Nrg3 
does not seem to function as a long-range chemoattractant for MGE-derived interneurons. 
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To investigate whether Nrg3 may function as a short-range chemoattractant for 
migrating interneurons, we carried out a new set of co-culture experiments in which COS 
cell aggregates, transfected with control or Nrg3 encoding plasmids, were placed at a 
relatively short distance from MGE explants (Figure 3A2). In this new set of experiments 
we used COS cells transfected with CRD-Nrg1 as a positive control, because this 
membrane bound form of Nrg1 has been shown to induce short-range chemoattraction 
during the migration of cortical interneurons through the subpallium (Flames et al., 2004). 
We found that both CRD-Nrg1 and Nrg3 evoke a potent chemoattractive effect on 
migrating interneurons, which can be visualized by the great abundance of cells 
accumulating around the proximal side of COS cell aggregates (Figure 3E–G, and 3I). 
Thus, Nrg3 induces a potent short-range chemoattractive effect on MGE-derived 
interneurons. 
Nrg3 chemoattraction requires ErbB4 function 
Because Nrg3 is thought to bind preferentially to ErbB4 receptors (Zhang et al., 1997), we 
next examined whether ErbB4 function mediates the chemoattractive responses elicited by 
Nrg3 in MGE-derived interneurons. To this end, we carried out a new set of co-culture 
experiments with MGE explants obtained from control and Erbb4 mutant embryos (Figure 
3J). Because loss of ErbB4 causes early lethality due to cardiac defects, Erbb4 mutants 
carried a human transgene under a cardiac-specific myosin promoter (HER4heart) to 
circumvent this problem (Tidcombe et al., 2003). In contrast to controls, we observed that 
Nrg3 does not exert any effect on MGE-derived cells obtained from Erbb4 mutant 
embryos (Figure 3L–O). Thus, ErbB4 is necessary for the migration of cortical 
interneurons in response to Nrg3. Altogether, these experiments indicate that the 
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chemoattractive effect elicited by Nrg3 on migrating interneurons is mediated by ErbB4 
function. 
Tangentially migrating MGE-derived interneurons prefer Cxcl12 to Nrg3 
It has been previously shown that the chemokine Cxcl12 strongly promotes the tangential 
migration of MGE-derived cells throughout the embryonic cortex. Cxcl12 is expressed by 
the meninges and in the SVZ of the pallium during embryonic development (Borrell and 
Marín, 2006; Stumm et al., 2003; Tiveron et al., 2006). Since Nrg3 is expressed in the CP 
from early stages of development (Figure 2A and 2A’), tangentially migrating interneurons 
encounter both cues as they reach the embryonic cortex. Both Cxcl12 and Nrg3 seem to 
function as chemoattractive factors for migrating MGE-derived interneurons, so we next 
explored whether interneurons display a preference for any of these molecules. To this end, 
we cultured MGE explants obtained from E13.5 embryos from GFP-expressing mice 
together with aggregates of COS cells placed at a short-distance and transfected with either 
a mock plasmid, Nrg3 or Nrg3 and Cxcl12 together (Figure 4A1). As expected, we 
observed that Cxcl12 enhances the migration of MGE-derived interneurons (Figure 4B, 
4D, and 4E). In addition, we found that Cxcl12 does not block the chemoattractive effect 
elicited by Nrg3 (Figure 4B–E). These results suggested that tangentially migrating MGE-
derived interneurons are equipped to respond to both Cxcl12 and Nrg3 simultaneously.  
We next wondered whether MGE-derived interneurons display any preference for 
Cxcl12 or Nrg3. To answer this question, we performed stripe choice assays using 
recombinant proteins, as described previously (Walter et al., 1987). In brief, E13.5 MGE 
explants obtained from GFP-expressing embryos were placed on top of stripes coated with 
a control peptide (GST), Nrg3-GST or recombinant Cxcl12 in alternate combinations 
(Figure 4A2), and their lane preference scored after 48 h. As expected, MGE-derived cells 
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showed no migratory preference when alternative stripes were coated with the same 
recombinant protein (GST/GST, Nrg3/Nrg3 or Cxcl12/Cxcl12) in control experiments 
(Figure 4I and data not shown). In contrast, MGE-derived interneurons displayed a strong 
preference for Nrg3-coated stripes compare to control lanes (Figure 4G and 4I). Moreover, 
MGE-derived cells exhibited a strong preference towards Cxcl12 when they were given 
the possibility to migrate on alternating stripes containing Nrg3 and Cxcl12 (Figure 4H and 
4I). Taken together, these experiments suggest that tangentially migrating interneurons can 
respond simultaneously to Cxcl12 and Nrg3, but they display stronger affinity for the 
chemokine. These observations are consistent with the in vivo behavior of MGE-derived 
interneurons, which initially disperse through the cortex via Cxcl12-rich territories (MZ 
and SVZ) without accumulating in the CP (López-Bendito et al., 2008).  
Nrg3 overexpression promotes interneuron invasion of the CP in vivo 
We next wondered whether unbalancing the normal levels of Nrg3 in the developing CP 
would interfere with the migration of cortical interneurons in vivo. To this end, we 
electroporated the ventricular zone of the pallium in E14.5 Nkx2-1Cre;Ai9 embryos with 
either Gfp expressing plasmids or a combination of Gfp and Nrg3 (Figure 5A), and 
examined the distribution of MGE-derived interneurons (labeled with tdTomato) at E18.5. 
We observed that overexpression of Nrg3 does not seem to disrupt the migration of 
pyramidal cells (Figure 5B, 5E). In contrast, overexpression of Nrg3 accelerates the 
invasion of the CP by MGE-derived interneurons (Figure 5C, 5D, and 5F). Thus, these 
results suggested that Nrg3 promotes the intracortical migration of MGE-derived 
interneurons in vivo.  
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In vivo loss of Nrg3/ErbB4 signaling disrupts interneuron lamination  
To examine the long-term consequences of disrupting Nrg3 signaling in vivo, we 
generated mice carrying conditional Nrg3 alleles (Figure S3). To delete Nrg3 specifically 
from developing pyramidal cells, we used Nex-Cre mice, in which exon 2 of the NeuroD6 
locus has been replaced by Cre recombinase (Goebbels et al., 2006). We found that early 
deletion of Nrg3 in pyramidal cells does not alter their laminar position in the postnatal 
cortex (Figure S4). Analysis of the distribution of Erbb4-expressing neurons in the 
somatosensory cortex of control and conditional Nrg3 mutants at P30 revealed no 
differences in the total density of Erbb4+ cells (controls: 783.28 ± 48.18 cells/mm2, Nrg3 
mutants: 923.69 ± 56.15 cells/mm2; n = 4, t-test p > 0.05). However, we observed that the 
laminar location of Erbb4-expressing neurons was significantly different between control 
and conditional Nrg3 mutants, with a deep to superficial layer shift in the distribution of 
Erbb4-expressing cells in mutants compared to controls (Figure 6A–C). Since ErbB4 is 
primarily expressed by PV+ interneurons in the cortex (Fazzari et al., 2010; Neddens and 
Buonanno, 2010), we also analyzed their distribution at P30. Similar to the analysis of 
Erbb4-expressing neurons, we found no differences in the total density of PV+ 
interneurons (controls: 281.88 ± 25.29 cells/mm2, Nrg3 mutants: 258.68 ± 36.1 cells/mm2; 
n = 5, t-test p > 0.05), but a subtle shift in their laminar distribution (Figure 6D–F). To 
determine whether these differences in the laminar distribution of cortical interneurons 
were already present in the early postnatal cortex, we examined the distribution of Lhx6-
expressing neurons in the somatosensory cortex of control and conditional Nrg3 mutants at 
P4. We found a significant shift towards superficial layers in the distribution of Lhx6-
expressing cells in conditional Nrg3 mutants compared to controls (Figure 6G–I). 
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Altogether, these results revealed that conditional deletion of Nrg3 from developing 
pyramidal cells disrupts the laminar distribution of cortical interneurons. 
Since Nrg3 signaling requires ErbB4 function in cortical interneurons (Figure 3J–O), 
we next wondered whether similar layering defects exist in conditional Erbb4 mutants. To 
this end, we bred Lhx6-Cre mice with mice carrying loxP-flanked (F) Erbb4 alleles and 
analyzed the distribution of PV+ interneurons in the somatosensory cortex. We have 
previously shown that the total number of interneurons in the cortex in Lhx6-Cre;Erbb4F/F 
mice is similar to controls at P30 (del Pino et al., 2013). However, detailed analysis of the 
laminar distribution of PV+ interneurons revealed a clear shift in conditional Erbb4 
mutants, with fewer cells in deep layers and more cells in superficial layers than in controls 
(Figure 7A–F). To elucidate whether this defect reflects an overall shift in the allocation of 
cortical interneurons, we examined the laminar distribution of specific cohorts of PV+ cells 
by injecting BrdU in control and conditional Erbb4 mutants at E12.5 or E15.5 (Figure 7A).  
We found that interneurons born at E12.5 and E15.5 tend to occupy deep and superficial 
layers of the cortex, respectively, in both controls and Erbb4 mutants (Figure 7B–E, 7G, 
and 7H). However, the distribution of PV+ interneurons was shifted towards progressively 
more superficial layers for both cohorts of cells in conditional Erbb4 mutants compared to 
controls (Figure 7G and 7H), a result that is consistent with the overall shift in the 
distribution of PV+ interneurons toward superficial layers (Figure 7F). Altogether, these 
experiments indicate that ErbB4 mediates the function of Nrg3 in the intracortical 
migration of interneurons, and that this signaling system is required for the appropriate 
laminar allocation for these cells. 
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DISCUSSION 
We have identified Nrg3 as a factor regulating the assembly of inhibitory neurons in the 
developing cerebral cortex. We found that Nrg3 is highly expressed by developing 
pyramidal cells during the entire period of interneuron allocation in the cerebral cortex.  
Gain and loss of function experiments suggest that Nrg3 functions specifically as a 
chemoattractive signal regulating CP invasion by interneurons, and that this process is 
mediated by the tyrosine kinase receptor ErbB4. Nrg3 is therefore a critical mediator in the 
assembly of inhibitory circuits, controlling the orderly entry of interneurons in the CP prior 
to their subsequent sorting into specific cortical layers.  
Nrg3 in cortical interneuron development 
Nrg3 was identified as a neural tissue-enriched molecule nearly twenty years ago (Zhang et 
al., 1997), yet very little is known about its role in brain development and function. An 
isoform of NRG3 that is specifically expressed in the human embryonic central nervous 
system has been shown to influence oligodendrocyte survival in vitro (Carteron et al., 
2006). In addition, recent in vitro experiments revealed that MGE-derived interneurons are 
able to respond to Nrg3 (Li et al., 2012; Rakic et al., 2015). This is consistent with the 
observation that MGE-derived interneurons express ErbB4 (Flames and Marín, 2005; Yau 
et al., 2003), and that ErbB4 is the preferred receptor for Nrg3 (Zhang et al., 1997). Our 
experiments confirm and extend these observations by demonstrating a specific role for 
Nrg3 in the entry of GABAergic interneurons in the developing CP in vivo.  
Our results suggest that Nrg3 functions as a short-range chemoattractive factor for 
cortical interneurons. Analysis of the amino acid sequence of human Nrg3 reveals 
important homologies with Nrg1, but contrary to many Nrg1 family members the 
 15 
extracellular domain of Nrg3 lacks Ig-like domains (Zhang et al., 1997). Although the 
structure of Nrg3 resembles more closely that of type I/II Nrg1, our experiments indicate 
that Nrg3 functions largely as a short-range chemoattractant, most similar to membrane-
bound forms of Nrg1. Even if Nrg3 is released in vivo through post-translational 
proteolysis, our experiments suggest that its diffusion is likely restricted to near the CP. In 
this context, it is worth noting that Nrg3 contains a mucin-like Ser/Thr rich region 
containing abundant sites for O-linked glycosylation (Zhang et al., 1997), which may 
function to limit its diffusion.  
Constitutive Nrg3 mutant mice have decreased impulsivity, increased activity in a 
novel open field, and deficient prepulse inhibition of the acoustic startle response and fear 
conditioning (Hayes et al., 2016; Loos et al., 2014). Interestingly, these defects are not 
rescued by overexpression of Nrg3 in the adult medial prefrontal cortex – the region 
responsible for impulsive responding (Loos et al., 2014). In contrast, systemic 
overexpression of Nrg3 during early postnatal development via subcutaneous injections 
leads to alterations in anxiety and social behaviors in adulthood (Paterson and Law, 2014). 
It is conceivable that the behavioral deficits reported in these mice are due to defects in the 
distribution of cortical interneurons, reinforcing the notion that Nrg3 function during 
development is required for normal brain function.  
Neuregulins have been also implicated in other steps in the development of MGE-
derived cortical interneurons (Rico and Marín, 2011). In particular, Nrg1 has been shown 
to regulate the wiring of PV+ interneurons in the postnatal cortex (Fazzari et al., 2010; 
Ting et al., 2011). Since Nrg3 expression is maintained in pyramidal cells into adulthood, 
it remains to be explored whether this neuregulin may contribute to the regulation of the 
connectivity of PV+ interneurons. Nrg3 is also expressed in cortical interneurons in the 
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postnatal brain (Loos et al., 2014), which suggests that its function in cortical circuit 
assembly might be more complex than previously anticipated.  
A hierarchical organization of guidance cues for cortical interneurons 
Our experiments suggest that the transition from tangential to radial migration and the 
allocation of interneurons inside the CP depends on a delicate balance between two 
chemoattractive factors, Ngr3 and Cxcl12, which seems to be hierarchically organized. 
Our experiments indicate that tangentially migrating interneurons show a prominent 
preference for Cxcl12 during their tangential dispersion through the cortex, and it is only 
when they lose their responsiveness to this molecule that they steer towards the source of 
Nrg3 in the CP. One caveat of the in vitro experiments is that the tested MGE interneurons 
are younger than they would normally be when they encounter both molecules in the 
cortex in vivo. Our in vivo analyses, however, strongly suggest that interneurons respond 
to both of these cues during the migration through the cortex. 
Cxcl12 is strongly expressed by the meninges and by intermediate progenitor cells 
transitorily present in the SVZ (Stumm et al., 2003; Tham et al., 2001; Tiveron et al., 
2006), and is also expressed by cells in the SP (Stumm et al., 2007). Cxcl12 is a potent 
long-range chemoattractant for MGE derived interneurons in vitro (Li et al., 2008; López-
Bendito et al., 2008), but its limited diffusion in vivo would explain the relative 
confinement of interneurons to the migratory streams found in the cortex. Consistent with 
this idea, mouse mutants with altered expression of Cxcl12 in the meninges or in the SVZ 
have defects in the intracortical migration of interneurons that are specific to the affected 
migratory route (Abe et al., 2015; Sessa et al., 2010; Tiveron et al., 2006; Zarbalis et al., 
2012). 
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The molecular mechanisms regulating the tangential to radial switch in the migration 
of cortical interneurons and the subsequent CP invasion remains unknown. The exit of 
interneurons from the migratory streams is coordinated with the loss of responsiveness to 
Cxcl12 (Li et al., 2008), and this is ultimately linked with the entry of interneurons into the 
CP. The analysis of Cxcr4 and Cxcr7 mutants revealed many interneurons inside CP at 
relatively early embryonic stages (Li et al., 2008; López-Bendito et al., 2008; Sánchez-
Alcaniz et al., 2011; Tanaka et al., 2010; Tiveron et al., 2006; Wang et al., 2011), a finding 
that can now be interpreted as a premature response to Nrg3. 
The timing of interneuron responses to the cues guiding their migration into the cortex 
seems tightly regulated and it is important for the final distribution of interneurons in 
different regions and layers of the cortex. Premature entry in the cortical plate, as observed 
in Cxcr4 and Cxcr7 mutants, cause defects in the regional and laminar distribution of 
interneurons in the adult cortex (Li et al., 2008; López-Bendito et al., 2008; Sánchez-
Alcaniz et al., 2011; Tanaka et al., 2010; Wang et al., 2011). Similarly, removal of Nrg3, a 
factor that facilitates CP entry, also disrupts laminar distribution in the adult cortex. Of 
note, the laminar defects observed in Cxcr4/Cxcr7 and Nrg3 mutants are complementary 
(accumulation of interneurons in deep or superficial layers for Cxcr4/Cxcr7 and Nrg3 
mutants, respectively). These observations reinforce the notion that Cxcl12 and Nrg3 play 
sequential and largely complementary roles in the migration of cortical interneurons. 
Pyramidal cells and microglia regulate the distribution of interneurons 
Studies over the last decade have revealed some important aspects on the regulation of 
layer acquisition by cortical interneurons. Most notably, several studies have suggested 
that pyramidal cells regulate the laminar distribution of cortical interneurons (Hevner et al., 
2004; Lodato et al., 2011; Pla et al., 2006). In reeler mice, for example, the distribution of 
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interneurons follow that of pyramidal cells, which is roughly inverted compared to control 
mice (Hevner et al., 2004; Pla et al., 2006). This phenotype does not depend on Reelin 
signaling, but rather on the abnormal distribution of pyramidal cells (Pla et al., 2006). 
Subsequent work revealed that experimental manipulations causing the formation of 
clusters of misplaced pyramidal cells under the white matter are sufficient to misguide 
interneurons into these ectopic locations (Lodato et al., 2011). These results reinforced the 
notion that pyramidal cells produce factors that guide the migration of cortical 
interneurons, and our experiments now reveal that Nrg3 is one of these molecules. In 
addition, recent work has shown that Cxcl12 may also play additional functions in the 
postnatal differentiation of cortical interneurons, affecting their laminar distribution and 
synapse development (Vogt et al., 2014; Wu et al., 2016). 
Recent work suggests that microglia may also regulate the laminar positioning of 
cortical interneurons (Squarzoni et al., 2014). Microglia invade the cortex following a 
gradient similar to interneurons (Cunningham et al., 2013; Squarzoni et al., 2014; Swinnen 
et al., 2013). In the absence of microglia, or when microglia is abnormally activated, 
MGE-derived interneurons enter the CP prematurely and adopt abnormal laminar 
distribution patterns (Squarzoni et al., 2014). It remains to be tested whether microglia 
exert their function through the regulation of chemokines or by directly acting on signals 
produced by pyramidal cells.  
Nrg3, cortical interneurons and psychiatric disorders 
Human genetic studies have associated variation in the NRG3 gene with attention-
deficit/hyperactivity disorder (ADHD) and schizophrenia (Chen et al., 2009; Kao et al., 
2010; Meier et al., 2013; Morar et al., 2011; Sonuga-Barke et al., 2008). Although some of 
these studies await replication in larger genome-wide association studies (Schizophrenia 
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Working Group of the Psychiatric Genomics, 2014), increasing evidence suggests that 
pathological variants in the neuregulin signaling pathway are present in at least a subset of 
phenotypically distinct patients (Hatzimanolis et al., 2013). In mice, Nrg3 overexpression 
in the adult prefrontal cortex increases impulsivity (Loos et al., 2014), a feature that is 
observed in ADHD and schizophrenia patients (Aron and Poldrack, 2005; Nolan et al., 
2011). Loss of Nrg3 in mice has also been linked with behavioral deficits observed in 
psychotic disorders (Hayes et al., 2016). Considering that the balance between excitatory 
and inhibitory circuits seems compromised in schizophrenia patients, and that this might be 
caused by subtle defects in the function of GABAergic interneurons (Lewis et al., 2012), 
our results suggest a possible mechanism through which changes in NRG3 expression may 
influence the assembly of inhibitory circuits in the cerebral cortex. 
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EXPERIMENTAL PROCEDURES  
Animals 
This study was performed in strict accordance with Spanish, United Kingdom and 
European Union regulations. The local ethical committees at the Instituto de Neurociencias 
and King’s College London approved all experimental procedures involving animals. 
Nkx2-1Cre (Xu et al., 2008) and Ai9 (Rosa26 Reporter CAG-boosted tdTomato) mice 
(Madisen et al., 2010) were maintained in a C57BL/6 background, while wild type and 
ubiquitously expressing GFP mice (Hadjantonakis et al., 1998) were maintained in a CD1 
background. HER4heart transgenic mice, which express a human ErbB4 (HER4) cDNA 
under the control of the cardiac-specific HMC (myosin heavy chain) promoter, were 
maintained in a mixed C57b/6 and 129/SvJ background. The generation of ErbB4 mutant 
mice (Gassmann et al., 1995) and HER4heart transgenic mice (Tidcombe et al., 2003) has 
been previously described. Lhx6-Cre;Erbb4F/F mice were generated by breeding Lhx6-Cre 
mice (Fogarty et al., 2007)with mice carrying loxP-flanked (F) Erbb4 alleles (Golub et al., 
2004).  For birthdating experiments, pregnant females received intraperitoneal injections at 
E12.5 (three injections in 18 h) or E15.5 (three injections in 12 h) with 50 mg/kg BrdU (5-
bromo- 2′-deoxyuridine, B5002 Sigma-Aldrich).  
We generated a pre-conditional allele for Nrg3 by crossing mice carrying a knockout 
first Nrg3 allele (Knockout Mouse Program of the University of California, Davis) 
(Skarnes et al., 2011) with mice ubiquitously expressing Flp (Rodriguez et al., 2000). We 
then produced conditional Nrg3 mutants by crossing Nex-Cre (Goebbels et al., 2006) or 
Nestin-Cre (Tronche et al., 1999) with mice carrying conditional Nrg3 alleles. To genotype 
these mice, we used the following primer sequences: CSD-loxP, 5’-
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GAGATGGCGCAACGCAATTAATG-3’; CSD-Nrg3-SR1: 5’-
AGTGCTGGAAATAAAAGCATGGTGGG-3’; CSD-Nrg3-wtF: 5’-
CATATTACATACAGAATTCAAAGATAGGC-3’; CSD-Nrg3-wtR: 5’-
CCAGTGCTGGAATTTGAATACAA-3’. CSD-loxP and CSD-Nrg3-SR1 primers were 
used to detect the knockout first allele. CSD-Nrg3-wtF and CSD-Nrg3-wtR were used to 
detect the wild-type allele and the wild-type pre-conditional allele generated after Flp-
mediated recombination. 
In situ hybridization and immunohistochemistry 
For in situ hybridization, postnatal mice were perfused transcardially with 4% 
paraformaldehyde (PFA) in PBS and the dissected brains were fixed overnight at 4°C in 
the same solution. Brains were then cut at 40 μm on a freezing microtome and free-floating 
coronal sections were subsequently hybridized with digoxigenin-labeled probes as 
described before (Flames et al., 2007). The following cDNA probes were used in this 
study: Nrg3 and ErbB4 (kindly provided by Cary Lai, Indiana University, Bloomington, 
Indiana, USA), GAD67 (kindly provided by John Rubenstein, UCSF, USA), Lhx6 (kindly 
provided by V. Pachnis, The Crick Institute, London, UK), Cxcr4 (Invitrogen, 174412), 
Cxcl12 (Invitrogen, 3483088), Cdh6 and Cdh9 (kindly provided by C Redies, University of 
Jena, Germany), Ephb6 (Source BioScience, EST clone IMAGp998L1511952Q), Epha6 
(kindly provided by V. Borrell, Instituto de Neurociencias, Alicante, Spain), Sema7a 
(Source BioScience, EST clone IMAGp998I188236Q). 
For immunohistochemistry, postnatal mice were perfused transcardially with 4% PFA 
in PBS and the dissected brains were fixed for 2 h at 4°C in the same solution. Brains were 
sectioned at 60 μm on a vibratome or 40 μm on a freezing microtome and free-floating 
coronal sections were then subsequently processed for immunohistochemistry as 
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previously described (Pla et al., 2006). The following primary antibodies were used: rat 
anti-BrdU (1:200, ab6326, Abcam), rat anti-Ctip2 (1:500, ab18465, Abcam), rabbit anti-
Cux1 (CDP-M222 1:100, Santa-Cruz), rabbit anti-DsRed (1:500, 632496, Clontech), 
chicken anti-GFP (1:1000, GFP-1020, Aves Labs), and rabbit anti-PV (1:3000, Swant). 
The following secondary antibodies were used: goat anti-chicken 488, donkey anti-rabbit 
555, donkey anti-mouse 488, and goat anti-rat IgG (H+L) Alexa Fluor® 555 conjugate 
(Molecular Probes). Cell nuclei were stained with 5 μM 4ʹ′-6-diamidino-2-phenylindole 
(DAPI) in PBS and sections mounted with Mowiol (Sigma) with NPG (Calbiochem). 
In utero electroporation 
E14.5 timed-pregnant ICR or Nkx2-1Cre;Ai9 females were deeply anesthetized and the 
abdominal cavity cut open. Embryos were exposed in the uterus, and 1 µg/µl pCAG-Gfp or 
Nrg3 (kindly provided by C. Lai, Indiana University, Bloomington, USA and subcloned 
into pCAGGS) plasmids were injected into the lateral ventricle of the telencephalon 
through the uterine wall. Square electric pulses of 45V and 50ms were passed through the 
uterus five times, spaced 950ms, using a square pulse electroporator. The uterine horns 
were placed back in the abdominal cavity, which was then suture closed and the female 
was allowed to recover. 
Explant cultures 
For COS cell confrontation assays, COS7 cells were transfected with plasmids encoding 
Rfp alone, Rfp and Cxcl12, Rfp and Nrg3, Rfp and CRD-Nrg1 or Rfp and Ig-Nrg1 and cell 
aggregates were prepared by diluting transfected cells with Matrigel in a 1:1 proportion. 
After jellification, COS cell aggregates were cut with a scalpel in small rectangular prisms 
of approximately 400x400x800 µm and confronted to MGE explants obtained from GFP-
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expressing transgenic mice in 3-D Matrigel pads. The cDNA used for expression of Cxcl12 
was obtained from Invitrogen (clone number: 3483088; accession number: BC006640). 
Nrg3 was kindly provided by Cary Lai (Indiana University, Bloomington, Indiana, USA). 
The sequences used for expression of type I NRG1 (Ig-Nrg1) and type III NRG1 (CRD-
Nrg1) correspond to the accession numbers AY648976 and AY648975, respectively. For 
Cxcl12 chemokine-blocking experiments, SU6656 (Sigma, 330161-87-0) was added to the 
medium at a final concentration of 15 µM. Previous worked has shown that Src functions 
downstream of Cxcr4 activation (Cabioglu et al., 2005). 
In vitro focal electroporation 
Coronal slice cultures were obtained as described previously (Anderson et al., 1997). A 
pCAGG based dsRed plasmid was pressure injected focally into the MGE of coronal slice 
cultures by a Pneumatic PicoPump through a glass micropipette. Slices were then 
electroporated within a setup of two horizontally oriented platinum electrodes powered by 
a Electro-Square-Porator, as described before (Flames et al., 2004). 
Time-lapse videomicroscopy 
Slices were transferred to the stage of an upright Leica DMLFSA or inverted Leica 
DMIRE2 microscope coupled to a confocal spectral scanning head (Leica TCS SL) and 
viewed through 10–60X water immersion or 20X oil objectives. Slices were continuously 
superfused with warmed (32°C) artificial cerebrospinal fluid at a rate of 1 ml/minute or 
maintained in supplemented Neurobasal medium. To block Cxcl12 function, SU6656 
(Sigma, 330161-87-0) was added to the medium at a final concentration of 15 µM. 
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Stripe assay 
Purified CXCL12 protein was obtained from PeproTech (250-20A) and used at 1 ng/µl. 
GST and EGF-Nrg3-GST were purified using standard protocols and used at 10 µg/ml. 
Alternating lanes, 50 µm wide, were laid down on a poly-lysine-coated plastic dish. 
Alexa555-labeled anti-rabbit IgGs were added to the GST, EGF-Nrg3-GST and CXCL12 
protein solution for lane identification. The lanes were further coated with laminin. MGE 
explants were dissected out of GFP+ brain slices, plated on top of the protein stripes, and 
incubated in methylcellulose-containing Neurobasal medium for 48 h. 
FACS 
We dissected the sensorimotor cortex of E17.5 embryos and P4 pups following in utero 
electroporation at E14.5. Cortical tissue was dissociated as described previously (Catapano 
et al., 2001). GFP+ cells were purified using fluorescent activated cell sorting (FACSARIA 
III, BD Biosciences) and the resulting pellet kept at -80 ºC. 
Taqman gene expression assays 
We isolated GFP+ pyramidal cells by FACS at E17.5 and P4 after in utero electroporation 
at E14.5. mRNA was then extracted using the RNeasy Micro Kit (Qiagen) according to the 
manufacturer’s instructions. RNA quality was assessed using a bioanalyzer (Agilent 
Technologies) and then retro-transcribed into single-stranded cDNA. The RNA was sent to 
Unidad Genómica (Fundación Parque Científico de Madrid) for quality control and retro-
transcription. Relative gene expression levels from three independent samples were 
analyzed using custom designed TaqMan® low-density array (TLDA) plates (Micro 
Fluidic Cards, Applied Biosystems, Foster City, USA). Each plate contained duplicates for 
all the genes shown in Table S1. Data were collected and analyzed using the threshold 
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cycle (Ct) relative quantification method. The house keeping gene 18 RNA was included 
in the array for assessing RNA quality and sample normalization. 
Western blot 
Cortical lysates were prepared from P30 control, Nestin-Cre;Nrg3F/F and Nex-Cre;Nrg3F/F 
mutants as described before (Fazzari et al., 2010; Vullhorst et al., 2009) and blotted using 
mouse anti-E-Actin (1:4000, Sigma) and rabbit anti-Nrg3 (1:500, Abcam).  Signals were 
detected with a luminescent image analyzer (LAS-1000PLUS; Fuji-firm) and quantified 
with Quantity One 1D Analysis Software (Bio-Rad Laboratories). 
Image analysis and quantification 
Images were acquired using fluorescence microscopes (DM5000B, CTR5000 and DMIRB 
from Leica or Apotome.2 from Zeiss) coupled to digital cameras (DC500 or DFC350FX, 
Leica; OrcaR2, Hamamatsu), or in an inverted Leica TCS SP8 confocal microscope. All 
images were analyzed with ImageJ (Fiji). For the quantification of migration in MGE 
explants, the distance migrated by the 30 furthest cells was measured. For the 
quantification of short-range chemoattraction, the colocalizing area between MGE and 
COS cells was measured. For the analysis of the interneuron angle of migration, we draw a 
grid of virtual radial lines (lines perpendicular to the ventricular zone and the pial surface) 
and oriented each cell in relation to the most adjacent ‘radial line’. Cells that deviated less 
than 25° from radial lines were considered as radially oriented; those that deviate more 
than 25° were designated as tangentially oriented. We systematically exclude from this 
analysis those cells located in the more lateral or medial regions of the cortex, so that the 
curvature of the slice in those regions would not interfere with our analysis (Martini et al., 
2009). For the quantification of cell migration in MGE explants we measured the distance 
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migrated by the 30 furthest cells and normalized the average migrated distance to the 
distance between MGE and COS explants. For the quantification of the colocalizing area 
between migrating interneurons and COS cells in the short-distance confrontation assays, 
we quantified the colocalizing area using ImageJ (Fiji). Stripes were quantified by 
counting the number of neurons contained in a virtual grid containing five black and five 
red lines. The same area was used for all explants. Sections from control and mutant mice 
were imaged during the same imaging session. Data acquisition was performed using the 
same laser power, photomultiplier gain, pinhole and detection filter settings (1024x1024 
resolution, 12 bits). Quantifications were done using ImageJ (Fiji). Layers were drawn 
following nuclear staining. For in situ hybridization the area quantified was divided in ten 
equal bins and the percentage of cells in each bin was calculated. The bins were then 
matched to the appropriate layers.  
Statistical analyses 
Statistical analysis was carried out in SPSS (SPSS Inc.). P values below 0.05 were 
considered statistically significant. Data are presented as mean and SEM throughout the 
manuscript (Table S3). Normality and variance tests were first applied to all experimental 
data. When data followed a normal distribution, paired comparisons were analyzed with t-
test, while multiple comparisons were analyzed using either ANOVA with post-hoc 
Bonferroni correction (equal variances) or the Welch test with post-hoc Games-Howell 
(different variances). A 𝜒2-test was applied to analyze the distribution of cells in either bins 
or layers. 
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Figure legends 
 
Figure 1. Identification of factors regulating the invasion of the cortical plate by 
interneurons. (A) Schematic of the experimental design. A plasmid encoding Gfp was 
electroporated in the neocortex of E14.5 mouse embryos. The electroporated region was 
then isolated at E17.5 or P4, and GFP+ cells were dissociated and recovered via FACS. (B, 
C) Distribution of GFP+ pyramidal cells at E17.5 (B) and P4 (C), prior to isolation. (D) 
FACS of GFP+ cells. (E) Among the pool of candidate genes (Table S1), we found 44 that 
were differentially expressed between the two stages. t-test, p values are shown in Source 
data 2. Histograms show average ± SEM. Scale bar equals 250 µm. 
 
Figure 2. Expression of Nrg3 mRNA in the developing mouse cortex. (A–E’) Coronal 
sections through the telencephalon of E13.5 (A, A’), E15.5 (B, B’), E18.5 (C, C’), P2 (D, 
D’), P4 (E, E’) embryos and neonates showing mRNA expression for Nrg3. Ac, anterior 
commissure; CP, cortical plate; H, Hippocampus; ic, internal capsule; LGE, lateral 
ganglionic eminence; MGE, medial ganglionic eminence; MZ, marginal zone; NCx, 
neocortex; PCx, piriform cortex; Str, striatum; SVZ, subventricular zone; Th, thalamus; 
VZ, ventricular zone; I-VI, cortical layers I to VI. Scale bars equal 250 µm.  
 
Figure 3. Nrg3 functions as a short-range chemoattractant for MGE-derived interneurons 
and requires ErbB4 receptors. (A) Schematic of the experimental design. MGE explants 
were confronted to transfected COS cells located at relative long (A1) or short (A2) 
distances. (B–G) Migration of MGE-derived interneurons in response to mock- (B, E), Ig-
Nrg1- (C), CRD-Nrg1- (D) or Nrg3-transfected (D, G) COS cells located at relatively long 
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(B–D) and short (E–G) range. Dotted lines indicate the limits of the explants and COS cell 
aggregates. (H) Quantification of long-distance confrontation assays. Control: MGE versus 
mock, n = 19; MGE versus Ig-Nrg1, n = 24; one-way ANOVA, **p < 0.01. MGE versus 
Nrg3, n = 20; one-way ANOVA, p > 0.05. (I) Quantification of short-distance 
confrontation assays. Control: MGE versus mock, n = 29; MGE versus CRD-Nrg1, n = 24, 
MGE versus Nrg3, n = 27; one-way ANOVA, **p < 0.01. (J) Schematic of the 
experimental design. MGE explants were confronted to control and Nrg3 transfected COS 
cells located at relative short distances. (K, L, N, O) Migration of MGE-derived cells 
derived from Erbb4+/+;HER4heart (K, L) and Erbb4-/-;HER4heart (N, O) mice in response to 
mock- (K, N) o Nrg3-transfected (L, O) COS cell aggregates cultured in collagen matrices 
for 48 hours. (M) Quantification of confrontation assays. Erbb4+/+;HER4heart versus mock, 
n = 33; Erbb4+/+;HER4heart versus Nrg3, n = 25; Erbb4-/-;HER4heart versus mock, n = 15; 
Erbb4-/-;HER4heart versus Nrg3, n = 14; one-way ANOVA, ***p < 0.001. Histograms 
show average ± SEM. NCx, neocortex; MGE, medial ganglionic eminence. Scale bar 
equals 200 µm. 
 
Figure 4. MGE-derived interneurons display preferential responses to Cxcl12 and Nrg3. 
(A) Schematic of the experimental designs. MGE explants were confronted to transfected 
COS cells located at relative short distances (A1) or placed on coated matrices in stripe 
choice assays (A2). (B–D) Migration of MGE-derived interneurons in response to mock- 
(B), Nrg3- (C), or Nrg3- and Cxcl12-transfected (D) COS cells. Dotted lines indicate the 
limits of the explants and COS cell aggregates. (E) Quantification of MGE-derived 
interneurons migrating away from explants. MGE versus mock, n = 18; MGE versus Nrg3, 
n = 15; MGE versus Nrg3 + Cxcl12, n = 27; one-way ANOVA, ***p < 0.001. (F) 
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Quantification of short-distance confrontation assays. MGE versus mock, n = 18; MGE 
versus Nrg3, n = 15; MGE versus Nrg3 + Cxcl12, n = 27; one-way ANOVA, ***p < 
0.001, *p < 0.05. (G, H) Migration of MGE-derived cells in the stripe choice assay, with 
control and Nrg3-coated (G) or Nrg3- and Cxcl12-coated alternating stripes (H). (I) 
Quantification of stripe choice assays. Nrg3/Nrg3 (n = 11) versus Nrg3/GST (n = 20); one-
way ANOVA, ***p < 0.001. Cxl12/Cxl12 (n = 13) versus Nrg3/Cxcl12 (n = 18); one-way 
ANOVA, ***p < 0.001. Histograms show average ± SEM. NCx, neocortex; MGE, medial 
ganglionic eminence. Scale bar equals 200 µm. 
 
Figure 5. Nrg3 overexpression in pyramidal cells enhances interneuron invasion of the CP 
in vivo. (A) Schematic of the experimental design. The pallial ventricular zone of Nkx2-
1Cre;Ai9 embryos was electroporated at E14.5 with Gfp-expressing or Gfp- and Nrg3-
expressing plasmids, and the distribution of MGE-derived interneurons was analyzed at 
E18.5. (B, C, E, F) Distribution of MGE-derived interneurons (labeled with tdTomato) in 
the somatosensory cortex of E18.5 Nkx2-1Cre;Ai9 embryos following in utero 
electroporation of Gfp (B, C) or Gfp and Nrg3 (E, F) at E14.5. (D) Density of MGE-
derived cells in the CP; n = 6, t-test ***p < 0.001. Histograms show average ± SEM. CP, 
cortical plate; MZ, marginal zone; V and VI, cortical layers V and VI, respectively. Scale 
bar equals 200 µm. 
 
Figure 6. Abnormal lamination of cortical interneurons in conditional Nrg3 mutants. (A, 
B) Distribution of Erbb4-expressing interneurons in the somatosensory cortex of control 
(A) and conditional Nrg3 (B) mice at P30. (C) Quantification of the distribution of Erbb4-
expressing cells; n = 4, 𝜒2 test *p < 0.05. (D, E) Distribution of PV+ interneurons in the 
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somatosensory cortex of control (D) and conditional Nrg3 (E) mice at P30. (F) 
Quantification of the distribution of PV+ interneurons; n = 5, 𝜒2 test *p < 0.05. (G, H) 
Distribution of Lhx6-expressing cells in the somatosensory cortex of control (G) and 
conditional Nrg3 (H) mice at P4. (I) Quantification of the laminar distribution of Lhx6-
expressing cells; n = 5, *p < 0.05, 𝜒2 test). Histograms show average ± SEM. Scale bars 
equal 200 µm. 
 
Figure 7. Abnormal lamination of cortical interneurons in conditional Erbb4 mutants. (A) 
Schematic of the experimental design. (B–E) Laminar distribution of PV+ interneurons 
(red) and specific cohorts of PV+ interneurons labeled after BrdU-injections at E12.5 and 
E15.5 (red and green) in the somatosensory cortex of control and conditional Erbb4 mutant 
mice at P30. (F) Quantification of the distribution of PV+ interneurons; n = 5, 𝜒2 test *p < 
0.05. (G, H) Quantification of the distribution of specific cohorts of PV+ interneurons; n = 
5, 𝜒2 test *p < 0.05. Histograms show average ± SEM. Scale bar equals 200 μm.  
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Figure S1, related to Figure 1. Loss of chemokine signaling redirects cells towards the 
cortical plate. (A) Schematic of the experimental design. A plasmid encoding dsRed was 
focally electroporated in the MGE of E13.5 acute slices. After 36 h in culture, vehicle or 
SU6655 was added to the medium, and migrating neurons were analyzed 12 h later. (B, 
C) Distribution of MGE-derived interneurons in the developing pallium after 48 h in 
culture. (D, F) Time-lapse sequence of dsRed-electroporated interneurons migrating 
through the subpallium in a control (D) and SU6655-treated (F) slice culture. These 
neurons were recorded for more than 12 hours; only selected frames are displayed. Time 
is depicted as hours:minutes. White arrowheads mark the soma of interneurons; empty 
arrowheads indicate leading process branches. (E) Quantification of the percentage of 
radially oriented interneurons in the pallium of control and SU6655-treated slices.  Data 
are represented as mean ± SEM; n = 240 cells for each condition from 2 independent 
experiments. t-test ***p < 0.001. Histograms show average ± SEM. NCx, neocortex; 
MGE, medial ganglionic eminence. Scale bars equal 100 μm.
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Figure S2, related to Figure 1. Differentially 
expressed genes in pyramidal cells at perinatal 
stages. Coronal sections through the telencephalon 
of E17.5 (A, C, E, G) and P4 (B, D, F, H) mice 
showing mRNA distribution for several candidate 
genes whose expression is upregulated by 
late-born pyramidal cells at P4 compared to E17.5. 
H, Hippocampus; ic, internal capsule; NCx, 
neocortex; S, septum; Str, striatum; Scale bars 
equal 0 μm.
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Figure S3, related to Figure 6. Generation and characterization of Nrg3 conditional mutant mice. (A) 
Mice carrying a knockout-first allele were bred with pan-Flippase (FLP) mice to generate mice carrying a 
conditional (floxed) Nrg3 allele. These mice were subsequently crossed with Cre-expressing mouse 
strains to generate conditional Nrg3 mutant mice. The blots show genotyping band sizes for the 
knockout-first, floxed and wild type Nrg3 alleles using the primers indicated in the schemas. (B) 
Immunoblots and quantification of Nrg3 protein from cortical homogenates in control (Nrg3F/F) and two 
strains of conditional mutant mice (NestinCre/+;Nrg3F/F and NexCre/+;Nrg3F/F). The existence of a remnant 
of Nrg3 protein in NexCre/+;Nrg3F/F mice suggests that cells other than pyramidal cells express this protein 
in the cortex. ***p < 0.001; t-test; n = 4. Histograms show average ± SEM. (C-F) Expression of Nrg3 
mRNA in the forebrain of control (C, D) and Nrg3 mutant (E, F) mice at P30. CA3, field CA3; CPu, 
Caudoputamen; fi, fimbria; HC, hippocampus; LD, laterodorsal thalamic nucleus; MCx, motor cortex; 
MH, medial habenula; MD, mediodorsal thalamic nucleus; RS, retrospenial cortex; Rt, reticular nucleus; 
SSCx, somatosensory cortex; VPM, ventral posteriomedial thalamic nucleus; I to VI, cortical layers I o VI, 
respectively. Scale bars equal 800 µm.
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Figure S4, related to Figure 6. Normal lamination of pyramidal cells in Nrg3 
conditional mutants. (A, B, D, E) Distribution of Cux1 (A, B) and Ctip2 (D, E) 
expressing neurons in the somatosensory cortex of control (A, D) and 
conditional Nrg3 (B, E) mice at P30. (C) Quantification of the distribution of 
Cux1-expressing cells; n = 4, Chi-squared test p = 1. (F) Quantification of the 
distribution of Ctip2-expressing cells; n = 4, Chi-squared test p = 1.
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# Gene Symbol Locus Link Assay ID Public RefSeq
1 Cdh1 mCG20483 Mm00486918_m1 NM_009864.2
2 Cdh2 mCG141325 Mm00483213_m1 NM_007664.4
3 Cdh3 mCG20482 Mm01249209_m1 NM_007665.2
4 Cdh4 mCG116031 Mm00486926_m1 NM_009867.2
5 Cdh5 N.R. Mm03053719_s1 NM_009868.4
6 Cdhr5 mCG23289 Mm00511182_m1 NM_028069.3
7 Cdh6 mCG8950 Mm00483230_m1 NM_007666.3
8 Cdh7 mCG14554 Mm00556135_m1 NM_172853.2
9 Cdh8 mCG124257 Mm01242096_m1 NM_001039154.1
10 Cdh11 mCG125313 Mm00515462_m1 NM_009866.4
11 Cdh12 mCG19771 Mm01165359_m1 NM_001008420.2
12 Cdh13 mCG141363 Mm00490584_m1 NM_019707.4
13 Cdh15 mCG19581 Mm00483191_m1 NM_007662.2
14 Cdh16 mCG23406 Mm00483196_m1 NM_007663.2
15 Cdh17 mCG5094 Mm00490692_m1 NM_019753.4
16 Cdh20 mCG3576 Mm00457145_m1 NM_011800.4
17 Cdh22 mCG17522 Mm00558118_m1 NM_174988.3
18 Cdh23 mCG1819 Mm00465755_m1 NM_023370.2
19 Cdh24 mCG133655 Mm01313848_g1 NM_199470.2
20 Pcdh1 mCG142244 Mm00547091_s1 NM_029357.3
21 Pcdh7 mCG9825 Mm00479579_m1 NM_018764.2
22 Pcdh8 mCG19385 Mm00480660_m1 NM_001042726.3
23 Pcdh9 N.R. Mm03038601_m1 NM_001081377.1
24 Pcdh10 mCG7131 Mm00477987_s1 NM_001098171.
25 Pcdh11x mCG51196 Mm01221603_m1 NM_001081385.1
26 Pcdh12 mCG18330 Mm00450488_m1 NM_017378.2
27 Pcdh15 mCG114141 Mm00480870_m1 NM_001142735.1
28 Pcdh18 mCG7322 Mm00499890_m1 NM_130448.3
29 Pcdh20 mCG17884 Mm00724499_m1 NM_178685.5
30 Epha1 mCG17082 Mm00445804_m1 NM_023580.4
31 Epha2 mCG10037 Mm00438726_m1 NM_010139.2
32 Epha3 mCG127999 Mm00580743_m1 NM_010140.3
33 Epha4 mCG119512 Mm00433056_m1 NM_007936.3
34 Epha5 mCG5337 Mm00433074_m1 NM_007937.3
35 Epha6 mCG127847 Mm00433094_m1 NM_007938.2
36 Epha7 mCG14600 Mm00833876_m1 NM_010141.3
37 Epha8 mCG9328 Mm00433106_m1 NM_007939.2
38 Epha10 mCG17241 Mm00624498_m1 NM_177671.5
39 Ephb1 mCG140739 Mm00557961_m1 NM_173447.3
40 Ephb2 mCG120083 Mm01181015_m1 NM_010142.2
41 Ephb3 mCG129784 Mm00802553_m1 NM_010143.1
42 Ephb4 mCG6855 Mm01201157_m1 NM_001159571.1
43 Ephb6 mCG4984 Mm00432456_m1 NM_001146351.1
44 Efna1 mCG17554 Mm00438660_m1 NM_010107.4
45 Efna2 mCG13393 Mm00433011_m1 NM_007909.3
46 Efna3 mCG17541 Mm01212723_g1 NM_010108.1
47 Efna4 mCG17548 Mm00433013_m1 NM_007910.2
48 Efna5 mCG50503 Mm00438665_m1 NM_010109.3
Table S1. Candidate genes used in the analysis, related to Figure 1
49 Efnb1 mCG51675 Mm00438666_m1 NM_010110.4
50 Efnb2 mCG17314 Mm00438670_m1 NM_010111.5
51 Efnb3 mCG20906 Mm00433016_m1 NM_007911.5
52 Sema3b mCG18861 Mm01230580_g1 NM_001042779.1
53 Sema3c mCG6382 Mm00443121_m1 NM_013657.5
54 Sema3d mCG115650 Mm00712652_m1 NM_028882.4
55 Sema3e mCG148351 Mm00809130_s1 NM_011348.2
56 Sema3f mCG18872 Mm00441325_m1 NM_011349.3
57 Sema4b mCG19462 Mm00803797_m1 NM_013659.4
58 Sema4d mCG1273 Mm00443147_m1 NM_013660.3
59 Sema4g mCG16919 Mm00442518_m1 NM_011976.1
60 Sema5a mCG141513 Mm00436500_m1 NM_009154.2
61 Sema5b mCG130168 Mm00443163_m1 NM_013661.2
62 Sema6a mCG8025 Mm00444441_m1 NM_018744.2
63 Sema6c mCG13711 Mm00441345_m1 NM_011351.1
64 Sema7a mCG132078 Mm00441361_m1 NM_011352.2
65 Sema3a mCG16225 Mm00436469_m1 NM_009152.3
66 Sema4a mCG8826 Mm00443140_m1 NM_001163490.1
67 Sema4f mCG126253 Mm00441343_m1 NM_011350.3
68 Sema6b mCG22980 Mm00443176_m1 NM_001130456.1
69 Sema6d mCG142100 Mm00553142_m1 N.R.
70 Plxdc2 mCG19758 Mm00470649_m1 NM_026162.5
71 Plxna1 mCG126649 Mm00501110_m1 NM_008881.2
72 Plxna2 mCG116593 Mm00801930_m1 NM_008882.2
73 Plxna3 mCG21221 Mm00501170_m1 NM_008883.2
74 Plxna4 mCG141681 Mm00558881_m1 NM_175750.3
75 Plxnb1 mCG16096 Mm00555359_m1 NM_172775.2
76 Plxnb3 mCG8090 Mm00502216_m1 NM_019587.2
77 Plxnc1 mCG4296 Mm00450687_m1 NM_018797.2
78 Plxnd1 mCG132454 Mm01184367_m1 NM_026376.3
79 Plxnb2 mCG140951 Mm00507118_m1 NM_138749.2
80 Plxdc1 mCG21901 Mm00511436_m1 NM_028199.3
81 Wnt1 mCG18420 Mm00810320_s1 NM_021279.4
82 Wnt2 mCG13463 Mm00470018_m1 NM_023653.5
83 Wnt3 mCG19162 Mm00437336_m1 NM_009521.2
84 Wnt5a N.R. Mm03053674_s1 NM_009524.2
85 Wnt5b mCG131712 Mm00437350_m1 NM_009525.3
86 Nrg3 mCG112807 Mm01209104_m1 NM_001190187.1
87 Nrg1 mCG130630 Mm01212130_m1 NM_178591.2
88 Slc12a5 mCG17512 Mm00803929_m1 NM_020333.2
89 Cxcr7 N.R. Mm02619632_s1 NM_007722.3
90 Cxcr4 mCG20049 Mm01996749_s1 NM_009911.3
91 Sst mCG125080 Mm00436671_m1 NM_009215.1
92 Lhx6 mCG22275 Mm00748360_s1 NM_001083126.1
93 Htr3a mCG3840 Mm00442874_m1 NM_001099644.1
94 Cux1 mCG18016 Mm00501628_m1 NM_009986.3
95 Tbr1 mCG15138 Mm00493433_m1 NM_009322.3
Negative controls
Positive controls
Genes FC Relative to FC=1 SEM P value
Efnb1 0,131935146 -7,579481492 0,010858182 ***p <0.001
Wnt7b 0,148148267 -6,749994562 0,017206477 ***p <0.001
Epha3 0,219748185 -4,550663295 0,037137542 ***p <0.001
Pcdh18 0,219811865 -4,549344963 0,017100566 ***p <0.001
Wnt7a 0,232457458 -4,3018624 0,016432225 ***p <0.001
Ephb4 0,224967813 -4,445080319 0,022059064 ***p <0.001
Plxna2 0,265450635 -3,767178782 0,032048706 ***p <0.001
Cdh4 0,29277809 -3,415556127 0,021660232 ***p <0.001
Plxnb2 0,296951606 -3,367552082 0,025405263 ***p <0.001
Efnb2 0,299908779 -3,334347213 0,031361909 ***p <0.001
Plxnb1 0,339667339 -2,944056977 0,022038945 ***p <0.001
Plxna4 0,366218157 -2,730612832 0,016955931 ***p <0.001
Efna4 0,395010016 -2,531581376 0,06733275 ***p <0.001
Cdh2 0,428242303 -2,335126616 0,069073452 ***p <0.001
Cdh24 0,466286461 -2,144604408 0,018189949 ***p <0.001
Nrg1 0,56692132 -1,763913199 0,088376771 **p <0.01
Cdh8 0,57582162 -1,736648931 0,064383999 ***p <0.001
Plxna3 0,630977093 -1,584843588 0,080091429 **p <0.01
Epha7 0,6333961 -1,578790902 0,019024541 ***p <0.001
Epha5 0,646999177 -1,545597019 0,074545367 **p <0.01
Plxnc1 0,717391125 -1,393939742 0,021142439 ***p <0.001
Pcdh7 0,729026353 -1,371692526 0,102642193 *p <0.05
Ephb1 0,832465427 -1,201251088 0,038791808 ***p <0.001
Genes FC Relative to FC=1 SEM P value
Efnb3 1,427387934 1,427387934 0,122268558 *p <0.05
Sema6b 1,354327 1,354327 0,109117005 *p <0.05
Sema4a 1,690684 1,690684 0,292424279 *p <0.05
Plxna1 2,027104 2,027104 0,223528133 **p <0.01
Sema4f 2,260192 2,260192 0,228407523 **p <0.01
Efna3 2,185114 2,185114 0,421707061 *p <0.05
Cdh6 2,548228 2,548228 0,074748942 ***p <0.001
Pcdh15 2,592109 2,592109 0,123544917 ***p <0.001
Ephb6 2,957104 2,957104 0,118839367 ***p <0.001
Cdh20 3,301568 3,301568 0,38665171 **p <0.01
Pcdh11x 4,405326 4,405326 0,164233786 ***p <0.001
Nrg3 3,026187 3,026187 0,883286483 **p <0.01
Plxnd1 5,129877 5,129877 0,537959669 ***p <0.001
Pcdh20 5,730245 5,730245 0,24173881 ***p <0.001
Epha6 5,898654 5,898654 0,784251166 ***p <0.001
Plxdc2 7,286740 7,286740 0,91754569 ***p <0.001
Epha8 7,465011 7,465011 0,166917298 ***p <0.001
Efna5 7,852177 7,852177 0,307935615 **p <0.01
Sema7a 8,325405038 8,325405038 1,209628999 **p <0.01
Downregulated P4
Upregulated P4
Table S2. Differentially expressed genes between E17.5 and P4, related to Figure 1
FIGURE 1 Measurement Values N Statistical P value
Fig 1E Fold change P4/E17.5 (mean ± SEM) Shown separately in Source data 2 2 independent experiments Student t-test Source data 2
FIGURE 3 Measurement Values N Statistical P value
Control: 1 ± 0.06; Ig-Nrg1: 1.33 ± 0.08 Control: 19 explants; Ig-Nrg1: 24 explants One way-ANOVA p < 0.01 (**)
Control: 1 ± 0.06; Nrg3: 1.13 ± 0.06 Control: 19 explants; Nrg3: 20 explants One way-ANOVA p = 0.157
Control: 2.7 ± 0.6%; CRD-Nrg1: 8.7 ± 1.7% Control: 24 explants; CRD-Nrg1: 29 explants One way-ANOVA p < 0.01 (**)
Control: 2.7 ± 0.6%; Nrg3: 6.8 ± 0.9% Control: 24 explants; Nrg3: 27 explants One way-ANOVA p < 0.01 (**)
Erbb4+/+;HER4heart. Mock: 1.9 ± 0.3%; Nrg3: 7.6 ± 0.8 % Erbb4+/+;HER4heart. Mock: n = 33 explants Nrg3: n = 25 explants One way-ANOVA p < 0.001 (***)
Erbb4-/-;HER4heart. Mock: 2.1 ± 0.6%; Nrg3: 2.1 ± 0.5% Erbb4-/-;HER4heart. Mock: n = 15 explants Nrg3: n = 14 explants One way-ANOVA p = 0.999
FIGURE 4 Measurement Values N Statistical P value
Control: 1 ± 0.07; Nrg3: 1.5 ± 0.06 Control: n = 18 explants; Nrg3:  n = 15 explants One way-ANOVA p < 0.05 (*)
Control: 1 ± 0.07; Nrg3 + Cxcl12: 2.1 ± 0.1 Control: n = 18 explants; Nrg3 + Cxcl12: n = 27 explants One way-ANOVA p < 0.001 (***)
Control:  2.2 ± 0.7; Nrg3: 7 ± 1.3 Control: n = 18 explants; Nrg3: n = 15 explants One way-ANOVA p < 0.05 (*)
Control:  2.2 ± 0.7; Nrg3+Cxcl12:  9.2 ± 1 Control: n = 18 explants; Nrg3 + Cxcl12: n = 27 explants One way-ANOVA p < 0.001 (***)
Nrg3/Nrg3: 48.08 ± 1.65%; Nrg3 vs GST: 43.41 ± 5.48% Nrg3/Nrg3: n = 11; Nrg3/GST: n = 20 One way-ANOVA p < 0.001 (***)
Cxcl12/Cxcl12: 50.9 ± 0.54%; Nrg3/Cxcl12: 24.34 ± 2.8% Cxcl12/Cxcl12: n = 13; Nrg3/Cxcl12: n = 18 One way-ANOVA p < 0.001 (***)
FIGURE  5 Measurement Values N Statistical P value
Fig 5D Density of Nkx2.1+ in CP (mean ± SEM) Control: 3607 ± 166.6 cells/mm2; Nrg3: 4740.3 ± 143.3 cells/mm2 Control: n = 6 embryos; Nrg3: n = 6 embryos Student t-test p < 0.001 (***)
FIGURE  6 Measurement Values N Statistical P value
Fig 6C Erbb4+ cells (%) (mean ± SEM) 
Controls: 10.12 ± 0.73 % [I], 13.65 ± 2.04% [II-III], 13.53 ± 1.05% [IV], 24.86 ± 1.14% [V], 
37.83 ± 0.78% [VI]; Nrg3 mutants: 9.38 ± 0.7% [I], 19.37 ± 0.37% [II-III], 18.65 ± 0.95% [IV], 
21.96 ± 0.33% [V], 30.63 ± 1.71% [VI]
n = 4 for each genotype χ2
p < 0.05 (*) for 
layers II-III, IV, V, 
VI 
Fig 6F PV+ cells (%) (mean ± SEM) 
Controls: 0.32 ± 0.24 % [I], 12.72 ± 0.8% [II-III], 29.41 ± 0.87% [IV], 37.82 ± 0.53% [V], 19.7 ± 
0.44% [VI]; Nrg3 mutants: 0.31 ± 0.09% [I], 16.36 ± 0.59% [II-III], 30.88 ± 1.23% [IV], 35.74 ± 
0.93% [V], 16.69 ± 1.28% [VI]
n = 5 for each genotype χ2
p < 0.05 (*) for 
layer II-III
Fig 6I Lhx6+ cells (%) (mean ± SEM) Controls: 4.93 ± 1.09% [I], 30.17 ± 1.71% [II-III/IV], 41.16 ± 0.99% [V], 23.73 ± 1.29% [VI]; Nrg3 mutants: 6.2 ± 1.38% [I], 35.28 ± 1.49% [II-III/IV], 39.61 ± 1% [V], 19.04 ± 1.8% [VI] n = 5 for each genotype χ
2 p < 0.05 (*) for 
layers II-III and IV
FIGURE  7 Measurement Values N Statistical P value
Fig 7F Densiy of PV+ interneurons (mean ± SEM) 
Controls:8.85 ±5.50 cells/mm2 [I], 144.29 ± 19.22 cells/mm2 [II-III],244.44 ± 16.21 cells/mm2 
[IV], 274.78 ± 11.69 cells/mm2 [V], 147.37 ± 12.49 cells/mm2 [VI]; Erbb4 mutants: 20.32 ± 
4.51 cells/mm2 [I], 193.27 ±7.95 cells/mm2 [II-III], 198.97 ± 10.37 cells/mm2 [IV], 241.67 ± 
23.97 cells/mm2 [V], 79.9 ±10.06 cells/mm2 [VI]
n = 5 for each genotype χ2
p < 0.05 (*) for 
layers II-III and VI
Fig 7G PV+/BrdU 12.5 cells (%) (mean ± SEM) Controls: 4.38± 0.09% [II-III], 13.74 ±3.89% [IV], 43.47 ± 5.18% [V], 38.19 ± 2.44% [VI]; Erbb4 mutants: 6.1 ± 2.26% [II-III], 15.17 ±2.75% [IV], 58.34 ± 3.34% [V], 21.55 ± 1.85% [VI] n = 5 for each genotype χ
2 p < 0.05 (*) for 
layers V and VI
Fig 7H PV+/BrdU 15.5 cells (%) (mean ± SEM) Controls: 53.3 ± 5.86% [II-III], 42.6 ± 3.42% [IV], 4.01 ±2.76% [V]; Erbb4 mutants: 74.35 ± 2.65% [II-III], 17.41 ±2.28% [IV], 11.13 ± 2.5% [V] n = 5 for each genotype χ
2 p < 0.05 (*) for 
layers II-III and IV
FIGURE S1 Measurement Values N Statistical P value
Fig S1E Radially migrating cells (%) (mean ± SEM) Vehicle: 10 ± 1.3%; Control: 32  ± 4.1% 2 independent experiments; n = 240 cells Student t-test p < 0.001 (***)
FIGURE S3 Measurement Values N Statistical P value
Fig S3B Relative Nrg3 protein levels (mean ± SEM) Control: 1 ± 0.21 a.u.; Nestin-Cre: 0.02 ± 0.02 a.u.; Nex-Cre: 0.18 ± 0.07 a.u. n = 4 for each genotype One way-ANOVA p < 0.001 (**)
FIGURE S4 Measurement Values N Statistical P value
Fig S4C Cux2+ cells (%) (mean ± SEM) 
Controls: 1.55 ± 0.64 % [I],40.12 ± 0.80% [II-III], 50.09 ± 1.65% [IV], 2.28 ± 0.29% [V], 5.97 ± 
1.50% [VI]; Nrg3 mutants: 1.07 ± 0.14 % [I], 42.32 ± 0.87 % [II-III], 49.50 ± 0.81% [IV], 2.57 ± 
0.24% [V], 4.53 ± 0.60% [VI]
n = 4 for each genotype χ2 p = 1
Fig S4F Ctip2+ cells (%) (mean ± SEM) 
Controls: 0.01 ± 0.01 % [I], 1.80 ± 0.06% [II-III], 3.28 ± 0.85% [IV], 23.33 ± 1.15% [V], 71.48 ± 
1.63% [VI]; Nrg3 mutants: 0.10 ± 0.00% [I], 1.15 ± 0.19% [II-III], 1.08 ± 0.07% [IV], 25.33 ± 
1.31% [V], 72.33 ± 1.43% [VI]
n = 4 for each genotype χ2 p = 1
Table S3. Summary of data and statistical analyses, related to Figures 1, 3, 4, 5, 6 and 7
Fig 3H Relative migrated distance (mean ± SEM) 
Fig 4I Cells in red (first) lane (%) (mean ± SEM)
Fig 4F Colocalizing area (%) (mean ± SEM)
Fig 3I Colocalizing area (%) (mean ± SEM)
Fig 3M Colocalizing area (%) (mean ± SEM)
Fig 4E Relative migrated distance (mean ± SEM) 
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Figure S1, related to Figure 1. Blocking Src inhibits Cxcl12-induced migration in 
MGE-derived interneurons. 
Figure S2, related to Figure 1. Differentially expressed genes in the developing 
mouse neocortex.  
Figure S3, related to Figure 6. Generation and characterization of Nrg3 conditional 
mutant mice.  
Figure S4, related to Figure 6. Normal lamination of pyramidal cells in Nrg3 
conditional mutants.  
Movie S1, related to Figure 1. Tangential migration of MGE-derived interneurons 
through the embryonic cortex 12 h after adding vehicle to the culture medium. 
Movie S2, related to Figure 1. Tangential migration of MGE-derived interneurons 
through the embryonic cortex 12 h after adding SU6655 to the culture medium.  
Table S1, related to Figure 1. Candidate genes used in the analysis. 
Table S2, related to Figure 1. Differentially expressed genes between E17.5 and P4. 
Table S3, related to Figure 1, 3, 4, 5, 6 and 7. Summary of data and statistical 
analyses. 
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